News of the index components BEL-20

Index

BEL20

BE0389555039

Market Closed - Euronext Bruxelles 12:05:02 2024-05-24 EDT			5-day change	1st Jan Change
3,970 ^PTS	-0.15%		-0.63%	+7.07%

05-10	Indexes already back on top
03-07	Aperam: forthcoming delisting from BEL20	CF

News of the index components

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RBC Raises Price Target on Anheuser-Busch Inbev to EUR75 From EUR73, Keeps Oppenheimer Rating ABI	05-08	MT
AB INBEV : UBS sticks Neutral ABI	05-08	ZD
Melexis N : introduces MLX90427 position sensing for steer-by-wire MELE	05-08	PU
AB INBEV : Goldman Sachs sticks Neutral ABI	05-08	ZD
Argenx SE Appoints Dr. Brian L. Kotzin as Non-Executive Director to the Board of Directors ARGX	05-08	CI
AB INBEV : Jefferies maintains a Buy rating ABI	05-08	ZD
Anheuser-Busch Inbev: Q1 Earnings Snapshot ABI	05-08	AQ
AB InBev: quarter in line, guidance maintained ABI	05-08	CF
Anheuser-Busch Inbev Q1 Underlying Earnings, Revenue Advance ABI	05-08	MT
AB InBev Powers Through Bud Light Boycott Anniversary with Consensus-beating First-quarter Revenue ABI	05-08	MT
Argenx : argenx announces results of Annual General Meeting of Shareholders ARGX	05-08	PU
AB InBev's shares rise on 'bruise-free' first quarter ABI	05-08	RE
AB InBev Volume Drops Less Than Expected Despite Bud Light Controversy -- Update ABI	05-08	DJ
Budweiser Maker AB InBev Profit Drops But Volumes Beat Expectations ABI	05-08	DJ
AB InBev Posts Lower Q1 Attributable Profit; Revenue Up ABI	05-08	MT
Beer giant AB InBev meets Q1 revenue forecasts ABI	05-08	RE
UCB : presents final open-label extension F®▼(fenfluramine) data at International Child Neurology Congress (ICNC) Annual Meeting UCB	05-08	PU
AB InBev Reports First Quarter 2024 Results ABI	05-08	BU
Beer giant AB InBev meets Q1 revenue forecasts ABI	05-08	RE
Solvay : 2024Q1 Earnings webcast presentation SOLB	05-07	PU
UCB : presents final open-label extension FINTEPLA®▼(fenfluramine) data at International Child Neurology Congress (ICNC) Annual Meeting UCB	05-07	PU
Argenx announces results of Annual General Meeting of Shareholders ARGX	05-07	GL
Lotus Bakeries : DISCLOSURE CONCERNING A TRANSPARENCY NOTIFICATION LOTB	05-07	PU
Umicore to Purchase Renewable Power From Finland’s Gasum UMI	05-07	MT
Transcript : Solvay SA, Q1 2024 Earnings Call, May 07, 2024 SOLB	05-07
Argenx : argenx to Present at BofA Securities 2024 Health Care Conference ARGX	05-07	PU
Groupe Bruxelles Lambert : GBL versterkt haar pan Europees platform voor investeringen in private activa met de opening van haar kantoor in Milaan en de aanwerving van Luca Bucelli GBLB	05-07	PU
Groupe Bruxelles Lambert : GBL Strengthens its Pan European Private Assets Investment Platform with the Opening of its Milan Office and the Appointment of Luca Bucelli GBLB	05-07	PU
Groupe Bruxelles Lambert : GBL renforce sa plateforme paneuropéenne d'investissement en actifs privés avec l'ouverture de son bureau de Milan et la nomination de Luca Bucelli GBLB	05-07	PU
Groupe Bruxelles Lambert : GBL Strengthens its Pan-European Private Assets Investment Platform with the Opening of its Milan Office and the Appointment of Luca Bucelli GBLB	05-07	PU
KBC Group: Update regarding the KBC Group share buyback programme KBC	05-07	GL
Solvay: lower underlying earnings in Q1 SOLB	05-07	CF
Chemicals group Solvay beats profit expectations as costs shrink SOLB	05-07	RE
Solvay first quarter 2024 results SOLB	05-07	GL
Argenx to Present at BofA Securities 2024 Health Care Conference ARGX	05-07	GL
Solvay SA Reports Earnings Results for the First Quarter Ended March 31, 2024 SOLB	05-06	CI
Groupe Bruxelles Lambert : GBL - Transactions on GBL shares 06-05-2024 GBLB	05-06	PU
Groupe Bruxelles Lambert : GBL - Transactions sur actions propres 06-05-2024 GBLB	05-06	PU
Groupe Bruxelles Lambert : Transactions on GBL shares from April 29, 2024 until May 3, 2024 (included) GBLB	05-06	PU
Sofina : Transactions on own shares – 06/05/2024 SOF	05-06	PU